MLYS

NASDAQ · Biotechnology

Mineralys Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$24.63

-0.50 (-1.99%)

As of Jun 21, 10:01 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 88%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +278.4% upside

Low Target $50.31

Average Target $93.19

High Target $121.15

Current Price $24.63

Current
$24.63

Target
$93.19

$50.31 $93.19 avg $121.15

Scenario Analysis

Bear Case

$50.31

104.3%

Low target

Base Case

$93.19

+278.4%

Avg target

Bull Case

$121.15

+391.9%

High target

Risk/Reward

3.8x

Highly favorable

Price in Context

52-Week High

$47.65

-48.3% from high

52-Week Low

$12.59

+95.6% from low

50-Day SMA

$33.44

-26.3% vs SMA

200-Day SMA

$27.93

-11.8% vs SMA

RSI (14)

35.0

Neutral

Target vs 52W High

$93.19

+95.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+12.0%
AMGN Amgen Inc	Hold	44	50%	$190.87	-44.6%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.1%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.5%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-31.2%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-37.5%